Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy

Figure 3

Decreased expression of FcγRIIb on memory B cells and plasmablasts from rheumatoid arthritis (RA) patients. Graphics summarize the expression of FcγRIIb on naïve B cells (a), memory B cells (b), and plasmablasts (c) from 18 RA patients and 13 healthy controls (HCs). Expression was quantified as mean fluorescence intensity (MFI). **P < 0.01, ***P < 0.001, two-tailed unpaired Student t test. Horizontal lines represent mean values.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us